Glaxo in Trouble over Claims Against Avandia Diabetes Drug

.

Glaxo in Trouble over Claims Against Avandia Diabetes Drug

There have been claims that Avandia diabetes drug is causing high risk of heart attacks and congestive heart failure to the users. And in this regard, around four Lawsuits have been filed in the UK against the producer, GlaxoSmithKline Plc (GSK).

Avandia was once known as the world's best diabetes pill but now has been surrounded amid several claims.

Daniel Slade is the lawyer involved and he is representing consumers in four lawsuits. In addition, there are 15 more clients in his list of this case. As revealed by him, the potential number of claims against GSK seems to go higher in a short period of time.

He commented during a telephonic interview: "We expect the number of claims to increase as there are potentially thousands of people out there who took Avandia in the U. K. Hopefully these claims will lead to more careful studies and checks on drugs that are widely marketed".

To settle down the claims of marketing Avandia along with other medication in an illegal manner; Glaxo had already paid more than $3 billion to the U. S. federal and state government.

David Daley, a spokesman for Brentford, UK-based Glaxo, while sympathizing with people suffering from health complications related with diabetes said that the company is bound to comment over any such cases.

 


Latest News

Latest Funding Value Snapchat at $10 billion
American Airlines Pulls Listing and Fares from Orbitz Due to Unsuccessful Effort
Is Burger King’s Deal with Tim Hortons Going to Affect Its Popularity?
Fans Show Twitch’s $970 Million Acquisition is Worth It
Ann Taylor (ANN) Shares Increase as Activist and Investors Put Pressure for Sale
Though The Market Basket Employees are Disappointed But They are not Giving up P
CME Group Faces Technical Glitch that Halts Trading for Four Hours
Survey Shows Lesser Number of Economists Believe US Monetary Policy to be on Rig
Burger King in Discussion with Canada's Tim Hortons for a Merger
Ackman and Valeant call for special meeting of Allergan shareholders
Home Depot to Bid Farewell to Blake as   CEO But He Continues to Stay As Chairma
UPS Store Data Breach: About 100,000 or More Customers Could Have Been Affected